Exploring type I angiotensin (AT1) receptor functions through gene targeting
The renin–angiotensin system (RAS) modulates a diverse set of physiological processes including development, blood pressure, renal function and inflammation. The principal effector molecule of this system, angiotensin II, mediates most of these actions. The classically recognized functions of the RA...
Gespeichert in:
Veröffentlicht in: | Acta physiologica Scandinavica 2004-08, Vol.181 (4), p.561-570 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The renin–angiotensin system (RAS) modulates a diverse set of physiological processes including development, blood pressure, renal function and inflammation. The principal effector molecule of this system, angiotensin II, mediates most of these actions. The classically recognized functions of the RAS are triggered via the type 1 (AT1) class of angiotensin receptors. Pharmacological blockade of the AT1 receptor lowers blood pressure and slows the progression of cardiovascular and renal diseases. Gene‐targeting technology provides an experimental approach for precisely dissecting the physiological functions of the RAS. Here, we review how gene‐targeting experiments have elucidated AT1 receptor functions. |
---|---|
ISSN: | 0001-6772 1365-201X |
DOI: | 10.1111/j.1365-201X.2004.01331.x |